N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine is a protected L-lysine derivative bearing an Fmoc group on the α-amino functionality and an allyoxycarbonyl (Alloc) carbamate on the ε-amino side chain. The molecule retains the stereogenic center of L-lysine while presenting orthogonally protected amine sites that can be selectively deprotected under peptide-synthesis-compatible conditions. The α-carboxyl is typically present as the free acid or as a handled building-block carboxylate depending on supplier specifications, and the protected amines enable stable storage while supporting stepwise coupling. The combination of Fmoc and Alloc protection provides a controlled reactivity profile for peptide building block preparation, side-chain functionalization, and downstream conversion of the lysine ε-amine into amide, urea, or other nitrogen-containing linkages.

1. Peptide Synthesis

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine serves as a lysine-specific protected amino acid building block for solid-phase peptide synthesis where orthogonal amine protection is required. The Fmoc group on the α-amine supports iterative N-terminal deprotection and coupling cycles, while the Alloc-protected ε-amine remains masked during backbone elongation to prevent undesired branching or cross-linking. The lysine side-chain carbamate can be selectively removed after chain assembly to enable formation of ε-amide bonds, ε-ureas, or further derivatization for lysine-containing sequences. The resulting peptide products and peptide fragments can be used for sequence optimization, backbone/side-chain SAR studies, and generation of defined peptide standards for biochemical assays.

2. Side-Chain Functionalization

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine is applied in chemical biology workflows that require controlled exposure of the lysine ε-amino group for post-synthetic modification. The Alloc carbamate functions as a removable protecting group on the side-chain nitrogen, enabling selective deprotection after peptide or intermediate assembly while the Fmoc-protected α-amino site remains protected during earlier steps. The liberated ε-amine can then undergo nucleophilic acylation to install reporter tags, affinity handles, or solubilizing substituents, supporting downstream conjugation chemistry. The orthogonal protection strategy supports construction of well-defined lysine-functionalized conjugates used in molecular recognition studies, assay development, and peptide-based probe generation.

3. Bioconjugation Chemistry

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine supports bioconjugation and labeling strategies where lysine residues are used as attachment points in defined molecular architectures. The protected ε-amine allows the compound to be incorporated into peptide scaffolds without premature reaction, while subsequent selective deprotection enables coupling to electrophiles such as activated carboxylic acids, isothiocyanates, activated esters, or heterobifunctional linkers. The presence of an Fmoc-protected α-amino group allows controlled handling as a building block during scaffold synthesis, reducing side reactions during intermediate preparation. The resulting lysine-bearing conjugates can be applied in biomolecule labeling, affinity reagent construction, and analytical tracer synthesis where precise attachment-site definition matters.

4. Chiral Amino Acid Intermediate

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine functions as a chiral amino acid intermediate for stereochemically defined nitrogen-containing fragments used in fine chemical synthesis. The L-configuration at the α-carbon is preserved through the protecting-group pattern, enabling downstream formation of stereodefined amide and urea motifs derived from the α- and ε-amino functionalities. Orthogonal protection supports sequential transformations, such as converting the α-amino site during peptide-like chemistry while leaving the ε-amine masked until the desired stage. The compound can therefore be employed to prepare chiral lysine-derived intermediates for medicinal chemistry programs, peptidomimetic scaffold construction, and process-oriented synthesis of nitrogen-rich building blocks.

5. Pharmaceutical Manufacturing

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine is relevant to pharmaceutical manufacturing contexts that involve peptide drug substance or peptide-like intermediate preparation requiring robust, orthogonally protected building blocks. The Fmoc/Alloc protection scheme enables controlled N-terminal deprotection and selective side-chain unmasking, which can be leveraged to standardize coupling sequences and reduce variability from side reactions involving the lysine ε-amino group. The protected amines improve handling stability during multi-step synthesis and support downstream formation of defined lysine-containing linkages in active pharmaceutical ingredient intermediates. The lysine-derived peptide building block concept aligns with scalable fine chemical synthesis practices where reproducible intermediate construction and predictable functional group availability are required for consistent downstream processing.

6. Process Chemistry Intermediate

N-α-Fmoc-N-ε-allyoxycarbonyl-L-lysine can be utilized as a process chemistry intermediate for manufacturing routes that demand orthogonal protection to manage reactivity during sequential transformations. The Fmoc carbamate provides a controlled N-protection handle for stepwise peptide coupling logic, while the Alloc carbamate on the ε-amine supports selective unmasking at a later stage to enable targeted derivatization. The compound's protected functional groups allow it to be stored and transported as a stable chiral feedstock for subsequent synthesis of lysine-containing intermediates, including peptide fragments, peptidomimetic precursors, and conjugation-ready scaffolds. The resulting downstream derivatives can be produced with defined chemoselectivity, supporting industrial chemical manufacturing of amino acid-derived building blocks used across peptide science and nitrogen-functionalized material development.

1. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

2. High fat diet and GLP-1 drugs induce pancreatic injury in mice

3. Identification, Localization in the Central Nervous System and Novel Myostimulatory Effect of Allatostatins in Tenebrio molitor Beetle

4. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors

5. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells